Skip to main
OFIX
OFIX logo

Orthofix International (OFIX) Stock Forecast & Price Target

Orthofix International (OFIX) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 62%
Buy 8%
Hold 31%
Sell 0%
Strong Sell 0%

Bulls say

Orthofix Medical Inc. has raised its long-term net sales compounded annual growth rate (CAGR) target to 6.5%-7.5%, reflecting a positive outlook for future revenue growth. The company reported an adjusted EBITDA of $23.9 million, marking a year-over-year increase and exceeding consensus estimates, alongside a notable expansion in adjusted EBITDA margins. Additionally, the strong performance in the global spine segment, with a 12% increase in Spine Fixation and a robust 30% rise in the enabling technology segment, further underscores Orthofix's market leadership and potential for continued growth in the orthopedic and spine solutions market.

Bears say

Orthofix Medical Inc. has faced significant operational challenges, particularly highlighted by the discontinuation of the M6-C and M6-L artificial disc product lines, which will contribute to a loss of $23.4 million in sales for 2024 and has negatively impacted EBITDA margins. Additionally, the company is under pressure from increasing competition from larger and better-financed rivals, as well as potential execution risks associated with the merger with SeaSpine, which may hinder its sales momentum and overall performance. Furthermore, a shift in the healthcare landscape, including decreasing reimbursement rates and heightened regulatory scrutiny, poses ongoing risks that could adversely affect Orthofix's earnings potential and market positioning.

Orthofix International (OFIX) has been analyzed by 13 analysts, with a consensus rating of Buy. 62% of analysts recommend a Strong Buy, 8% recommend Buy, 31% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Orthofix International and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Orthofix International (OFIX) Forecast

Analysts have given Orthofix International (OFIX) a Buy based on their latest research and market trends.

According to 13 analysts, Orthofix International (OFIX) has a Buy consensus rating as of Jul 27, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $35.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $35.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Orthofix International (OFIX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.